Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.75 |
| ▸ | LDHA | P00338 | 1/20 | 0.50 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.50 |
| ▸ | TET2 | Q6N021 | 5/20 | 0.42 |
| ▸ | TET3 | O43151 | 1/20 | 0.42 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.40 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.40 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.33 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Itaconate SCHEMBL29886131 | 1.00 | — | — | |
| Itaconate SCHEMBL21523 | 1.00 | — | — | |
| Itaconate SCHEMBL10757202 | 0.97 | ALOX15 (0.71) | ALOX15HSD17B10LDHASRRTET2 | |
| Itaconate SCHEMBL1888723 | 0.97 | ALOX15 (0.71) | ALOX15HSD17B10LDHASRRTET2 | |
| Itaconate SCHEMBL1184044 | 0.97 | ALOX15 (0.71) | ALOX15HSD17B10LDHASRRTET2 | |
| Itaconate SCHEMBL7518254 | 0.97 | ALOX15 (0.71) | ALOX15HSD17B10LDHASRRTET2 | |
| Itaconate SCHEMBL9244093 | 0.97 | ALOX15 (0.71) | ALOX15HSD17B10LDHASRRTET2 | |
| Itaconate SCHEMBL18554417 | 0.97 | ALOX15 (0.71) | ALOX15HSD17B10LDHASRRTET2 | |
| Itaconate SCHEMBL6552810 | 0.97 | ALOX15 (0.71) | ALOX15HSD17B10LDHASRRTET2 | |
| Itaconate SCHEMBL2397428 | 0.97 | ALOX15 (0.71) | ALOX15HSD17B10LDHASRRTET2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4566100-A1 | ANODE COMPOSITION CONTAINING ANIONIC BINDER | COATEX (FR) | 2025-06-11 | — | — | EP | claimed |
| WO-2024028544-A1 | ANODE COMPOSITION CONTAINING ANIONIC BINDER | COATEX (FR) | 2024-02-08 | — | — | WO | claimed |
| US-20150065366-A1 | Biomarkers for Bladder Cancer and Methods Using the Same | METABOLON, INC. | 2015-03-05 | — | — | US | claimed |
| EP-2776832-A1 | BIOMARKERS FOR BLADDER CANCER AND METHODS USING THE SAME | Metabolon, Inc. (US) | 2014-09-17 | — | — | EP | claimed |
| CN-103183764-A | Super absorbent polymer and method for forming the same | IND TECH RES INST | 2013-07-03 | — | — | CN | claimed |
| WO-2013070839-A1 | BIOMARKERS FOR BLADDER CANCER AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-05-16 | — | — | WO | claimed |
| US-5171451-A | Homo- and copolymers of (meth)acrylic acid and their salts; calcium carbonate saturation ratio retained; antiscaling agents, corrosion resistance | NALCO CHEMICAL COMPANY (US) | 1992-12-15 | — | — | US | claimed |
| CN-119968366-A | Oxadiazole derivatives, methods of preparation and use thereof in the treatment of inflammatory diseases | 西特瑞治疗有限公司 | 2025-05-09 | — | — | CN | disclosed |
| WO-2025072417-A1 | POLYSACCHARIDE DERIVATIVES | Nutrition & Biosciences USA 4, Inc. (US) | 2025-04-03 | — | — | WO | disclosed |
| CN-117731660-B | Use of ACOD gene activity inhibitor in preparation of medicine for treating cancer | 重庆医科大学附属第一医院 | 2025-02-14 | — | — | CN | disclosed |
| CN-118613596-A | Biomarkers for detecting and distinguishing invasive prostate cancer from inert forms and treatment of invasive prostate cancer | 约翰霍普金斯大学 | 2024-09-06 | — | — | CN | disclosed |
| CN-118453562-A | Nasal spray composition, nasal spray and application | 森宝(杭州)品牌运营有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-117731660-A | Application of ACOD1 gene activity inhibitor in preparation of medicines for treating cancers | 重庆医科大学附属第一医院 | 2024-03-22 | — | — | CN | disclosed |
| US-7939687-B2 | Sol-gel-polymer nanocomposite and methods thereof | CORNING INCORPORATED (US) | 2011-05-10 | — | — | US | disclosed |
| US-20110077333-A1 | BASIC STABILISATION SYSTEMS FOR EMULSION POLYMERISED RUBBER | BASF SE (DE) | 2011-03-31 | — | — | US | disclosed |
| US-20110070616-A1 | PRODUCTION OF ITACONIC ACID | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO | 2011-03-24 | — | — | US | disclosed |
| EP-2285887-A1 | BASIC STABILISATION SYSTEMS FOR EMULSION POLYMERISED RUBBERS | BASF SE (DE) | 2011-02-23 | — | — | EP | disclosed |
| CN-101200755-A | Bacterium identification reagent kit as well as preparation method and uses thereof | UNIV SOUTH CHINA AGRICULT (CN) | 2008-06-18 | — | — | CN | disclosed |
| WO-2006080741-A1 | SINTERED BIOACTIVE CERAMIC COMPOSITE IMPLANT AND PREPARATION THEREOF | LG CHEM, LTD. (KR) | 2006-08-03 | — | — | WO | disclosed |
| US-5250375-A | Photostructuring process | SIEMENS AKTIENGESELLSCHAFT (DE) | 1993-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110070616-A1 | PRODUCTION OF ITACONIC ACID | MAFG, SLC16A7, SLC16A1 | ALOX15 2706/4885HSD17B10 621/4885LDHA 579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.